MedTrace Logo

Intraoperative Detection of Residual BCC by Fast Raman

NCT03482622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-03-29

No results posted yet for this study

Summary

The main objective of this research is to develop a new scanning technology called the Fast Raman device, to accurately check the skin removed by the surgeon and detect any residual cancer cells; if found, additional skin can then be removed by surgeons on the same day. The device will be tested first for patients undergoing Mohs micrographic surgery, then be extended to wide-local excisions of basal cell carcinoma (BCC). This study will determine the validity (sensitivity/specificity) and reliability (inter- and intra-user variability) of the Fast Raman device for checking the completeness of tumour removal during Mohs micrographic surgery of BCC.

Conditions

  • Carcinoma, Basal Cell
  • Intraoperative BCC Detection by Fast Raman Device

Interventions

DIAGNOSTIC_TEST

Fast Raman

Fast Raman uses Raman spectroscopy to measure chemical profiles of tissue and provide a diagnostic map identifying BCC within 30 minutes.

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • Circle Nottingham NHS Treatment Centre

    collaborator UNKNOWN

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Ioan Notingher, PhD · University of Nottingham

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2023-03-31
Completion
2023-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482622 on ClinicalTrials.gov